Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Nina L. Hansen"'
Autor:
Susanna Søberg, Emilie S. Andersen, Niels B. Dalgaard, Ida Jarlhelt, Nina L. Hansen, Nina Hoffmann, Tina Vilsbøll, Anne Chenchar, Michal Jensen, Trisha J. Grevengoed, Sam A.J. Trammell, Filip K. Knop, Matthew P. Gillum
Publikováno v:
Molecular Metabolism, Vol 11, Iss , Pp 96-103 (2018)
Objective: Excessive alcohol consumption is a leading cause of global morbidity and mortality. However, knowledge of the biological factors that influence ad libitum alcohol intake may be incomplete. Two large studies recently linked variants in the
Externí odkaz:
https://doaj.org/article/be529766243b460f82294547288d04a1
Autor:
Niels B. Dalsgaard, Lærke S. Gasbjerg, Mads M. Helsted, Laura S. Hansen, Nina L. Hansen, Kirsa Skov-Jeppesen, Bolette Hartmann, Jens J. Holst, Tina Vilsbøll, Filip K. Knop
Publikováno v:
Bone. 170:116687
Autor:
Kathrine Rose, Filip K. Knop, Nina L. Hansen, Torben Hansen, Sofie Hædersdal, Tina Vilsbøll, Alexander S. Christensen, Jens J. Holst, Heidi Storgaard
Publikováno v:
Diabetes
Sulfonylureas (SUs) provide an efficacious first-line treatment in patients with hepatocyte nuclear factor 1α (HNF1A) diabetes, but SUs have limitations due to risk of hypoglycemia. Treatment based on the incretin hormones glucose-dependent insulino
Autor:
Mikkel B. Christensen, Asger Lund, Bolette Hartmann, Nina L. Hansen, Tore Magnussen, Filip K. Knop, Jens J. Holst
Publikováno v:
Diabetes. 70
To determine whether the glucagonotropic gut-derived hormone glucagon-like peptide 2 (GLP-2) might be exploited as a safeguard against insulin-induced hypoglycemia, we evaluated the effects of exogenous GLP-2 during hypoglycemia, euglycemia and hyper
Autor:
Signe Stensen, Tina Vilsbøll, Bolette Hartmann, Jens F. Rehfeld, Filip K. Knop, Niels B. Dalsgaard, Laura S. Hansen, Nina L. Hansen, Lærke S. Gasbjerg, Jens J. Holst
Publikováno v:
European journal of endocrinology. 184(3)
Aims The alpha-glucosidase inhibitor acarbose is believed to reduce plasma glucose by delaying hydrolysis of carbohydrates. Acarbose-induced transfer of carbohydrates to the distal parts of the intestine increases circulating glucagon-like peptide 1
Autor:
Tina Vilsbøll, Filip K. Knop, Torben Hansen, Jens J. Holst, Nina L. Hansen, Kathrine Rose, Heidi Storgaard, Sofie Hædersdal, Alexander S. Christensen, Ada Admin
Sulfonylureas (SUs) provide an efficacious first-line treatment in patients with hepatocyte nuclear factor 1-alpha (HNF1A)-diabetes, but SUs have limitations due to risk of hypoglycemia. Treatment based on the incretin hormones, glucose-dependent ins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ab5119769c4e2bd16b05f5fbb5e3b13
https://doi.org/10.2337/figshare.12410447
https://doi.org/10.2337/figshare.12410447
Autor:
Filip K. Knop, Tina Vilsbøll, Laura S. Hansen, Jens J. Holst, Niels B. Dalsgaard, Signe Stensen, Lærke S. Gasbjerg, Nina L. Hansen, Bolette Hartmann
Publikováno v:
Diabetes. 68
The glucose-lowering alpha-glucosidase inhibitor acarbose, is believed to act by delaying digestion and absorption of dietary carbohydrates. It has been shown that acarbose increases circulating glucagon-like peptide 1 (GLP-1). Using the GLP-1 recept
Autor:
Andreas Brønden, Bolette Hartmann, Christina Nexøe-Larsen, David P. Sonne, Tina Vilsbøll, Nina L. Hansen, Alexander S. Christensen, Jens J. Holst, Filip K. Knop
Publikováno v:
Diabetes. 68
A recent study in mice has demonstrated that the gut-derived hormone glucagon-like peptide-2 (GLP-2) may be involved in the regulation of gallbladder motility and induces gallbladder refilling. This study evaluated the effect of exogenous GLP-2 on po
Autor:
David P. Sonne, Tina Vilsbøll, Bolette Hartmann, Alexander S. Christensen, Nina L. Hansen, Filip K. Knop, Christina Nexøe-Larsen, Andreas Brønden, Jens F. Rehfeld, Jens J. Holst, Nicolai J Wever Albretchsen
Publikováno v:
Clinical and Translational Gastroenterology
Hansen, N L, Bronden, A, Nexoe-Larsen, C C, Christensen, A S, Sonne, D P, Rehfeld, J F, Wever Albretchsen, N J, Hartmann, B, Vilsbøll, T, Holst, J J & Knop, F K 2020, ' Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man : A Randomized, Double-Blinded, Crossover Study ', Clinical and Translational Gastroenterology, vol. 11, no. 12, e00257 . https://doi.org/10.14309/ctg.0000000000000257
Hansen, N L, Bronden, A, Nexoe-Larsen, C C, Christensen, A S, Sonne, D P, Rehfeld, J F, Wever Albretchsen, N J, Hartmann, B, Vilsbøll, T, Holst, J J & Knop, F K 2020, ' Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man : A Randomized, Double-Blinded, Crossover Study ', Clinical and Translational Gastroenterology, vol. 11, no. 12, e00257 . https://doi.org/10.14309/ctg.0000000000000257
INTRODUCTION: A recent study in mice points to the gut-derived hormone glucagon-like peptide 2 (GLP-2) as an important regulator of gallbladder motility inducing gallbladder relaxation and refilling. In this study, we evaluated the effect of exogenou